TIMP1 and cancer: These two targets have a few interacting proteins in common such as TIMP (1, 2 and 3), STAT 3, VEGF A, SRC, DCN, MMP 10 and CD 44 (Fig. S8) and all are supposed to be plum targets for cancer therapies.